Patents Assigned to Novoneuron, Inc
  • Patent number: 7220737
    Abstract: The present invention is directed to methods of treating patients for pain by administering noribogaine. Noribogaine may also be used to treat patients for the symptoms associated with withdrawal from drug dependency. In the latter case, the noribogaine treatment should be supplemented with the administration of an opioid antagonist such as naloxone.
    Type: Grant
    Filed: September 3, 1998
    Date of Patent: May 22, 2007
    Assignee: Novoneuron, Inc
    Inventor: Deborah C. Mash